A young man with acute dilated cardiomyopathy associated with methylphenidate
Tor-Bjarne Nymark1, A Hovland2, H Bjørnstad2, E W Nielsen1,31Section for Emergency Medicine; 2Department of Cardiology, Nordland Hospital, Bodø, Norway; 3University of Tromsø, Tromsø, NorwayAbstract: An 18-year-old obese man with a body mass index of 40, diagnosed with attention-deficit hyperactivit...
Published in: | Vascular Health and Risk Management |
---|---|
Main Authors: | , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Dove Press
2008
|
Subjects: | |
Online Access: | https://www.dovepress.com/a-young-man-with-acute-dilated-cardiomyopathy-associated-with-methylph-peer-reviewed-fulltext-article-VHRM |
id |
ftdovepress:oai:dovepress.com/1622 |
---|---|
record_format |
openpolar |
spelling |
ftdovepress:oai:dovepress.com/1622 2023-05-15T15:45:24+02:00 A young man with acute dilated cardiomyopathy associated with methylphenidate Nymark,Tor-Bjarne Hovland,A Bjørnstad,H Nielsen,E W 2008-04-11 text/html https://www.dovepress.com/a-young-man-with-acute-dilated-cardiomyopathy-associated-with-methylph-peer-reviewed-fulltext-article-VHRM en eng Dove Press info:eu-repo/semantics/altIdentifier/doi/10.2147/VHRM.S2410 https://www.dovepress.com/a-young-man-with-acute-dilated-cardiomyopathy-associated-with-methylph-peer-reviewed-fulltext-article-VHRM info:eu-repo/semantics/openAccess Vascular Health and Risk Management Case report info:eu-repo/semantics/article 2008 ftdovepress https://doi.org/10.2147/VHRM.S2410 2022-12-27T21:16:43Z Tor-Bjarne Nymark1, A Hovland2, H Bjørnstad2, E W Nielsen1,31Section for Emergency Medicine; 2Department of Cardiology, Nordland Hospital, Bodø, Norway; 3University of Tromsø, Tromsø, NorwayAbstract: An 18-year-old obese man with a body mass index of 40, diagnosed with attention-deficit hyperactivity disorder and treated with methylphenidate (Concerta®) was acutely admitted to hospital with hypoxia and dyspnoea. On investigation signs of liver-, renal-, and heart-failure were found. Noradrenalin infusion was started. Echocardiography showed dilated left ventricle and an ejection fraction (EF) of 25%. Liver function improved, noradrenalin and dobutamine were tapered, but three days after admission a new echocardiography showed an EF of 10%. The patient was transferred to the National Hospital (Rikshospitalet, Oslo), where intensified treatment including intra aortic balloon pump (IABP) was instituted. Cardiac function improved, and 3 weeks later the IABP was disconnected. EF at this point was 15%. The patient was denied heart transplantation due to various cofactors. The investigation concluded with a probable relationship between his cardiomyopathy and the use of methylphenidate (Concerta).Keywords: cardiomyopathy, heart failure, ADHD, methylphenidate Article in Journal/Newspaper Bodø Bodø Nordland Nordland Tromsø Nordland Dove Medical Press Norway Tromsø Bodø ENVELOPE(14.405,14.405,67.280,67.280) Vascular Health and Risk Management Volume 4 477 479 |
institution |
Open Polar |
collection |
Dove Medical Press |
op_collection_id |
ftdovepress |
language |
English |
topic |
Vascular Health and Risk Management |
spellingShingle |
Vascular Health and Risk Management Nymark,Tor-Bjarne Hovland,A Bjørnstad,H Nielsen,E W A young man with acute dilated cardiomyopathy associated with methylphenidate |
topic_facet |
Vascular Health and Risk Management |
description |
Tor-Bjarne Nymark1, A Hovland2, H Bjørnstad2, E W Nielsen1,31Section for Emergency Medicine; 2Department of Cardiology, Nordland Hospital, Bodø, Norway; 3University of Tromsø, Tromsø, NorwayAbstract: An 18-year-old obese man with a body mass index of 40, diagnosed with attention-deficit hyperactivity disorder and treated with methylphenidate (Concerta®) was acutely admitted to hospital with hypoxia and dyspnoea. On investigation signs of liver-, renal-, and heart-failure were found. Noradrenalin infusion was started. Echocardiography showed dilated left ventricle and an ejection fraction (EF) of 25%. Liver function improved, noradrenalin and dobutamine were tapered, but three days after admission a new echocardiography showed an EF of 10%. The patient was transferred to the National Hospital (Rikshospitalet, Oslo), where intensified treatment including intra aortic balloon pump (IABP) was instituted. Cardiac function improved, and 3 weeks later the IABP was disconnected. EF at this point was 15%. The patient was denied heart transplantation due to various cofactors. The investigation concluded with a probable relationship between his cardiomyopathy and the use of methylphenidate (Concerta).Keywords: cardiomyopathy, heart failure, ADHD, methylphenidate |
format |
Article in Journal/Newspaper |
author |
Nymark,Tor-Bjarne Hovland,A Bjørnstad,H Nielsen,E W |
author_facet |
Nymark,Tor-Bjarne Hovland,A Bjørnstad,H Nielsen,E W |
author_sort |
Nymark,Tor-Bjarne |
title |
A young man with acute dilated cardiomyopathy associated with methylphenidate |
title_short |
A young man with acute dilated cardiomyopathy associated with methylphenidate |
title_full |
A young man with acute dilated cardiomyopathy associated with methylphenidate |
title_fullStr |
A young man with acute dilated cardiomyopathy associated with methylphenidate |
title_full_unstemmed |
A young man with acute dilated cardiomyopathy associated with methylphenidate |
title_sort |
young man with acute dilated cardiomyopathy associated with methylphenidate |
publisher |
Dove Press |
publishDate |
2008 |
url |
https://www.dovepress.com/a-young-man-with-acute-dilated-cardiomyopathy-associated-with-methylph-peer-reviewed-fulltext-article-VHRM |
long_lat |
ENVELOPE(14.405,14.405,67.280,67.280) |
geographic |
Norway Tromsø Bodø |
geographic_facet |
Norway Tromsø Bodø |
genre |
Bodø Bodø Nordland Nordland Tromsø Nordland |
genre_facet |
Bodø Bodø Nordland Nordland Tromsø Nordland |
op_relation |
info:eu-repo/semantics/altIdentifier/doi/10.2147/VHRM.S2410 https://www.dovepress.com/a-young-man-with-acute-dilated-cardiomyopathy-associated-with-methylph-peer-reviewed-fulltext-article-VHRM |
op_rights |
info:eu-repo/semantics/openAccess |
op_doi |
https://doi.org/10.2147/VHRM.S2410 |
container_title |
Vascular Health and Risk Management |
container_volume |
Volume 4 |
container_start_page |
477 |
op_container_end_page |
479 |
_version_ |
1766379777682309120 |